Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
19.31
-1.86 (-8.79%)
At close: Oct 6, 2026, 4:00 PM EDT
19.64
+0.33 (1.71%)
Pre-market: Oct 7, 2026, 7:00 AM EDT
Immunome Market Cap
Immunome has a market cap or net worth of $2.19 billion as of October 6, 2026. Its market cap has increased by 103.52% in one year.
Market Cap
2.19B
Enterprise Value
1.68B
1-Year Change
103.52%
Ranking
Category
Stock Price
$19.31
ChartMarket Cap Chart
Since the IPO on October 2, 2020, Immunome's market cap has increased from $111.39M to $2.19B, an increase of 1,868.91%. That is a compound annual growth rate of 64.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 2.19B | -7.46% |
| Dec 31, 2025 | 2.37B | 257.53% |
| Dec 31, 2024 | 662.87M | 44.98% |
| Dec 29, 2023 | 457.21M | 1,605.70% |
| Dec 30, 2022 | 26.80M | -82.91% |
| Dec 31, 2021 | 156.82M | 53.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nurix Therapeutics | 2.32B |
| SELLAS Life Sciences Group | 2.29B |
| Harmony Biosciences Holdings | 2.29B |
| ADMA Biologics | 2.28B |
| Pharvaris | 2.17B |
| Maravai LifeSciences Holdings | 2.16B |
| Vera Therapeutics | 2.09B |
| Aurinia Pharmaceuticals | 2.09B |